Estimating Seroprevalence of Vaccine-Preventable Infections: Is It Worth Standardizing the Serological Outcomes to Adjust for Different Assays and Laboratories?

Epidemiology and Infection - United Kingdom
doi 10.1017/s095026881400301x

Related search